Notice2026-18825
Center for Scientific Review; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 15, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 177 (Tuesday, September 15, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 177 (Tuesday, September 15, 2026)]
[Notices]
[Page 58458]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18825]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Oncology
2--Translational Clinical Integrated Review Group, Translational
Immuno-oncology Study Section, October 15, 2026, 09:00 a.m. to October
16, 2026, 06:30 p.m., National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 which was published in the Federal
Register on September 01, 2026, 91 FR 56151, Doc. No. 2026-17896.
This meeting is being amended to change the meeting from a 2-day to
a 1-day meeting on October 15, 2026. And the start time to change from
9 a.m. to 8:30 a.m. The meeting is closed to the public.
Dated: September 10, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-18825 Filed 9-14-26; 8:45 am]
BILLING CODE 4167-05-P
</pre></body>
</html>Indexed from Federal Register on September 15, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.